Comment pls

2021-06-20

Comment pls

U.S. IPO Week Ahead: Billion-Dollar Deals Come To Market In A 12 IPO Week

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

cHao7
2021-06-20
cHao7
[真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香]
- llipinggg:
  [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [开心] [微笑] [开心]
- cHao7Replyllipinggg:
  whyyyyyyyy
cHao7
2021-06-20
cHao7
[难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过]
- B1B2:
  lol
- cHao7ReplyB1B2:
  [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑]
- cHao7ReplyB1B2:
  to the moon b1b2 [冷漠] [冷漠] [冷漠]
cHao7
2021-06-20
cHao7
[害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞]
llipinggg
2021-06-20
llipinggg
?
llipinggg
2021-06-20
llipinggg
?
Cyn198
2021-06-20
Cyn198
Done.
- cHao7:
  trend

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":164068713,"tweetId":"164068713","gmtCreate":1624161847032,"gmtModify":1703829868026,"author":{"id":3576377533433583,"idStr":"3576377533433583","authorId":3576377533433583,"authorIdStr":"3576377533433583","name":"llipinggg","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":25,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>Comment pls</body></html>","htmlText":"<html><head></head><body>Comment pls</body></html>","text":"Comment pls","highlighted":2,"essential":1,"paper":1,"likeSize":8,"commentSize":28,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/164068713","repostId":1199331995,"repostType":4,"repost":{"id":"1199331995","kind":"news","pubTimestamp":1624065374,"share":"https://www.laohu8.com/m/news/1199331995?lang=&edition=full","pubTime":"2021-06-19 09:16","market":"us","language":"en","title":"U.S. IPO Week Ahead: Billion-Dollar Deals Come To Market In A 12 IPO Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1199331995","media":"Renaissance","summary":"12 IPOs are scheduled to raise $5.6 billion in the week ahead led by two billion-dollar deals.Chinese freight platform Full Truck Alliance plans to raise $1.5 billion at a $19.7 billion market cap. The company’s platform connects shippers with truckers to facilitate shipments across distance ranges, cargo weights, and types. Full Truck states that it is the world's largest digital freight platform by gross transaction value , facilitating 22+ million fulfilled orders with GTV of nearly $8 billio","content":"12 IPOs are scheduled to raise $5.6 billion in the week ahead led by two billion-dollar deals.\nChinese freight platform&nbsp;Full Truck Alliance(YMM) plans to raise $1.5 billion at a $19.7 billion market cap. The company’s platform connects shippers with truckers to facilitate shipments across distance ranges, cargo weights, and types. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21.\nHealthcare manager&nbsp;Bright Health Group(BHG) plans to raise $1.3 billion at a $15.4 billion market cap. Bright Health seeks to employ a more consumer-centric approach to healthcare to improve consumer experiences. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding.\nData infrastructure provider&nbsp;Confluent(CFLT) plans to raise $713 million at a $10.0 billion market cap. Confluent data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company had more than 2,500 customers as of March 2021, with a dollar-based net retention rate of 117%.\nCar wash brand&nbsp;Mister Car Wash(MCW) plans to raise $600 million at a $5.3 billion market cap. Profitable with solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company offers a monthly subscription program called Unlimited Wash Club which had 1.4 million members as of 3/31/21, representing nearly two-thirds of total wash sales.\nDigital physicians network&nbsp;Doximity(DOCS) plans to raise $501 million at a $4.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. Fast growing and profitable, the company had over 1.8 million members as of 3/31/21, representing more than 80% of physicians across the country.\nCustomer experience software provider&nbsp;Sprinklr(CXM) plans to raise $361 million at a $5.5 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has attracted more than 1,000 customers, including over 50% of the Fortune 100. Sprinklr has improved its gross margins, though cash flow swung negative in 1Q FY22.\nHR platform provider&nbsp;First Advantage(FA) plans to raise $298 million at a $2.1 billion market cap. First Advantage provides technology solutions for screening, verifications, safety, and compliance related to human capital. Profitable with positive cash flow, the company derives most of its revenues from pre-onboarding screening, performing over 75 million screens on behalf of more than 30,000 customers in 2020.\nChinese social networking platform&nbsp;Soulgate(SSR) plans to raise $185 million at a $1.8 billion market cap. The company’s app Soul is a virtual social network created to address the drawbacks of current social media platforms. In March 2021, the company averaged 9.1 million DAUs, a 94% increase over the prior year period.\nDigital financial services provider&nbsp;AMTD Digital(HKD) plans to raise $120 million at a $1.4 billion market cap. AMTD Digital states that it is the \"fusion reactor\" at the core of the AMTD SpiderNet ecosystem, operating a comprehensive digital solutions platform in Asia. Profitable with explosive growth, the company primarily generates revenue from fees and commissions in two lines of business.\nOrgan bioengineering company&nbsp;Miromatrix Medical(MIRO) plans to raise $32 million at a $162 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable human organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product.\nKidney disease biotech&nbsp;Unicycive Therapeutics(UNCY) plans to raise $25 million at a $116 million market cap. The company’s candidates include Renazorb, which was in-licensed from Spectrum Pharmaceuticals, and UNI 494, which was in-licensed from Sphaera Pharmaceuticals. Unicycive began conducting preclinical trials on UNI 494 in 2020.\nAntibiotic biotech&nbsp;Acurx Pharmaceuticals(ACXP) plans to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year.\n<table>\n <tbody>\n <tr>\n <th>U.S. IPO Calendar</th>\n </tr>\n <tr>\n <th>Issuer Business</th>\n <th>Deal Size Market Cap</th>\n <th>Price Range Shares Filed</th>\n <th>Top Bookrunners</th>\n </tr>\n <tr>\n <td>Full Truck Alliance (YMM)Guiyang, China</td>\n <td>$1,485M$19,723M</td>\n <td>$17 - $1982,500,000</td>\n <td>Morgan StanleyCICC</td>\n </tr>\n <tr>\n <td>Digital freight platform that connects shippers and truckers in China.</td>\n </tr>\n <tr>\n <td>First Advantage (FA)Atlanta, GA</td>\n <td>$298M$2,097M</td>\n <td>$13 - $1521,250,000</td>\n <td>BarclaysBofA</td>\n </tr>\n <tr>\n <td>Provides background checks and other services to corporate customers.</td>\n </tr>\n <tr>\n <td>Sprinklr (CXM)New York, NY</td>\n <td>$361M$5,541M</td>\n <td>$18 - $2019,000,000</td>\n <td>Morgan StanleyJP Morgan</td>\n </tr>\n <tr>\n <td>Provides customer experience management software for enterprises.</td>\n </tr>\n <tr>\n <td>Bright Health Group (BHG)Minneapolis, MN</td>\n <td>$1,290M$15,385M</td>\n <td>$20 - $2360,000,000</td>\n <td>JP MorganGoldman</td>\n </tr>\n <tr>\n <td>Provides health insurance and other healthcare services.</td>\n </tr>\n <tr>\n <td>Confluent (CFLT)Mountain View, CA</td>\n <td>$713M$10,033M</td>\n <td>$29 - $3323,000,000</td>\n <td>Morgan StanleyJP Morgan</td>\n </tr>\n <tr>\n <td>Provides an enterprise platform that collects and processes real-time data streams.</td>\n </tr>\n <tr>\n <td>Doximity (DOCS)San Francisco, CA</td>\n <td>$501M$4,549M</td>\n <td>$20 - $2323,300,000</td>\n <td>Morgan StanleyGoldman</td>\n </tr>\n <tr>\n <td>Professional network for physicians with telehealth and scheduling tools.</td>\n </tr>\n <tr>\n <td>Soulgate (SSR)Shanghai, China</td>\n <td>$185M$1,824M</td>\n <td>$13 - $1513,200,000</td>\n <td>Morgan StanleyJefferies</td>\n </tr>\n <tr>\n <td>Provides the gamified social networking app Soul in China.</td>\n </tr>\n <tr>\n <td>Acurx Pharmaceuticals (ACXP)Staten Island, NY</td>\n <td>$15M$62M</td>\n <td>$5 - $72,500,000</td>\n <td>Alexander CapitalNetwork 1</td>\n </tr>\n <tr>\n <td>Phase 2 biotech developing antibiotics for antibiotic-resistant pathogens.</td>\n </tr>\n <tr>\n <td>Mister Car Wash (MCW)Tucson, AZ</td>\n <td>$600M$5,256M</td>\n <td>$15 - $1737,500,000</td>\n <td>BofAMorgan Stanley</td>\n </tr>\n <tr>\n <td>Leading national car wash brand with 344 locations across the US.</td>\n </tr>\n <tr>\n <td>AMTD Digital (HKD)Hong Kong, China</td>\n <td>$120M$1,388M</td>\n <td>$6.80 - $8.2016,000,000</td>\n <td>AMTD GlobalLoop Capital</td>\n </tr>\n <tr>\n <td>Digital financial services provider being spun out of AMTD.</td>\n </tr>\n <tr>\n <td>Miromatrix Medical (MIRO)Eden Prairie, MN</td>\n <td>$32M$162M</td>\n <td>$7 - $94,000,000</td>\n <td>Craig-Hallum</td>\n </tr>\n <tr>\n <td>Developing novel bioengineering technology for organ transplants.</td>\n </tr>\n <tr>\n <td>Unicycive Therapeutics (UNCY)Los Altos, CA</td>\n <td>$25M$116M</td>\n <td>$8.50 - $10.502,635,000</td>\n <td>Roth Cap.</td>\n </tr>\n <tr>\n <td>Early-stage biotech developing in-licensed therapies for kidney disease.</td>\n </tr>\n </tbody>\n</table>\nStreet research is expected for seven companies, and lock-up periods will be expiring for up to two companies.","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. IPO Week Ahead: Billion-Dollar Deals Come To Market In A 12 IPO Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. IPO Week Ahead: Billion-Dollar Deals Come To Market In A 12 IPO Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-19 09:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4435613-us-ipo-week-ahead-billion-dollar-deals-come-to-market-in-a-12-ipo-week>Renaissance</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n12 IPOs are scheduled to raise $5.6 billion in the week ahead led by two billion-dollar deals.\nChinese freight platform Full Truck Alliance(YMM) plans to raise $1.5 billion at a $19.7 billion market ...\n\n<a href=\"https://seekingalpha.com/article/4435613-us-ipo-week-ahead-billion-dollar-deals-come-to-market-in-a-12-ipo-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"YMM":"满帮","CXM":"Sprinklr, Inc.","CFLT":"Confluent, Inc.","FA":"First Advantage Corp.","MCW":"Mister Car Wash, Inc.","DOCS":"Doximity, Inc."},"source_url":"https://seekingalpha.com/article/4435613-us-ipo-week-ahead-billion-dollar-deals-come-to-market-in-a-12-ipo-week","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1199331995","content_text":"12 IPOs are scheduled to raise $5.6 billion in the week ahead led by two billion-dollar deals.\nChinese freight platform Full Truck Alliance(YMM) plans to raise $1.5 billion at a $19.7 billion market cap. The company’s platform connects shippers with truckers to facilitate shipments across distance ranges, cargo weights, and types. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21.\nHealthcare manager Bright Health Group(BHG) plans to raise $1.3 billion at a $15.4 billion market cap. Bright Health seeks to employ a more consumer-centric approach to healthcare to improve consumer experiences. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding.\nData infrastructure provider Confluent(CFLT) plans to raise $713 million at a $10.0 billion market cap. Confluent data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company had more than 2,500 customers as of March 2021, with a dollar-based net retention rate of 117%.\nCar wash brand Mister Car Wash(MCW) plans to raise $600 million at a $5.3 billion market cap. Profitable with solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company offers a monthly subscription program called Unlimited Wash Club which had 1.4 million members as of 3/31/21, representing nearly two-thirds of total wash sales.\nDigital physicians network Doximity(DOCS) plans to raise $501 million at a $4.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. Fast growing and profitable, the company had over 1.8 million members as of 3/31/21, representing more than 80% of physicians across the country.\nCustomer experience software provider Sprinklr(CXM) plans to raise $361 million at a $5.5 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has attracted more than 1,000 customers, including over 50% of the Fortune 100. Sprinklr has improved its gross margins, though cash flow swung negative in 1Q FY22.\nHR platform provider First Advantage(FA) plans to raise $298 million at a $2.1 billion market cap. First Advantage provides technology solutions for screening, verifications, safety, and compliance related to human capital. Profitable with positive cash flow, the company derives most of its revenues from pre-onboarding screening, performing over 75 million screens on behalf of more than 30,000 customers in 2020.\nChinese social networking platform Soulgate(SSR) plans to raise $185 million at a $1.8 billion market cap. The company’s app Soul is a virtual social network created to address the drawbacks of current social media platforms. In March 2021, the company averaged 9.1 million DAUs, a 94% increase over the prior year period.\nDigital financial services provider AMTD Digital(HKD) plans to raise $120 million at a $1.4 billion market cap. AMTD Digital states that it is the \"fusion reactor\" at the core of the AMTD SpiderNet ecosystem, operating a comprehensive digital solutions platform in Asia. Profitable with explosive growth, the company primarily generates revenue from fees and commissions in two lines of business.\nOrgan bioengineering company Miromatrix Medical(MIRO) plans to raise $32 million at a $162 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable human organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product.\nKidney disease biotech Unicycive Therapeutics(UNCY) plans to raise $25 million at a $116 million market cap. The company’s candidates include Renazorb, which was in-licensed from Spectrum Pharmaceuticals, and UNI 494, which was in-licensed from Sphaera Pharmaceuticals. Unicycive began conducting preclinical trials on UNI 494 in 2020.\nAntibiotic biotech Acurx Pharmaceuticals(ACXP) plans to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year.\n\n\n\nU.S. IPO Calendar\n\n\nIssuer Business\nDeal Size Market Cap\nPrice Range Shares Filed\nTop Bookrunners\n\n\nFull Truck Alliance (YMM)Guiyang, China\n$1,485M$19,723M\n$17 - $1982,500,000\nMorgan StanleyCICC\n\n\nDigital freight platform that connects shippers and truckers in China.\n\n\nFirst Advantage (FA)Atlanta, GA\n$298M$2,097M\n$13 - $1521,250,000\nBarclaysBofA\n\n\nProvides background checks and other services to corporate customers.\n\n\nSprinklr (CXM)New York, NY\n$361M$5,541M\n$18 - $2019,000,000\nMorgan StanleyJP Morgan\n\n\nProvides customer experience management software for enterprises.\n\n\nBright Health Group (BHG)Minneapolis, MN\n$1,290M$15,385M\n$20 - $2360,000,000\nJP MorganGoldman\n\n\nProvides health insurance and other healthcare services.\n\n\nConfluent (CFLT)Mountain View, CA\n$713M$10,033M\n$29 - $3323,000,000\nMorgan StanleyJP Morgan\n\n\nProvides an enterprise platform that collects and processes real-time data streams.\n\n\nDoximity (DOCS)San Francisco, CA\n$501M$4,549M\n$20 - $2323,300,000\nMorgan StanleyGoldman\n\n\nProfessional network for physicians with telehealth and scheduling tools.\n\n\nSoulgate (SSR)Shanghai, China\n$185M$1,824M\n$13 - $1513,200,000\nMorgan StanleyJefferies\n\n\nProvides the gamified social networking app Soul in China.\n\n\nAcurx Pharmaceuticals (ACXP)Staten Island, NY\n$15M$62M\n$5 - $72,500,000\nAlexander CapitalNetwork 1\n\n\nPhase 2 biotech developing antibiotics for antibiotic-resistant pathogens.\n\n\nMister Car Wash (MCW)Tucson, AZ\n$600M$5,256M\n$15 - $1737,500,000\nBofAMorgan Stanley\n\n\nLeading national car wash brand with 344 locations across the US.\n\n\nAMTD Digital (HKD)Hong Kong, China\n$120M$1,388M\n$6.80 - $8.2016,000,000\nAMTD GlobalLoop Capital\n\n\nDigital financial services provider being spun out of AMTD.\n\n\nMiromatrix Medical (MIRO)Eden Prairie, MN\n$32M$162M\n$7 - $94,000,000\nCraig-Hallum\n\n\nDeveloping novel bioengineering technology for organ transplants.\n\n\nUnicycive Therapeutics (UNCY)Los Altos, CA\n$25M$116M\n$8.50 - $10.502,635,000\nRoth Cap.\n\n\nEarly-stage biotech developing in-licensed therapies for kidney disease.\n\n\n\nStreet research is expected for seven companies, and lock-up periods will be expiring for up to two companies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":162,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":10,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":4905550,"commentId":"4905550","gmtCreate":1624162003068,"gmtModify":1663229471146,"authorId":3571630433284403,"author":{"id":3571630433284403,"idStr":"3571630433284403","authorId":3571630433284403,"name":"cHao7","avatar":"https://static.tigerbbs.com/3800b5d66328f3184368a219227b02a3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":164068713,"objectIdStr":"164068713","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"[真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香]","text":"[真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香]","html":"[真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香] [真香]","likeSize":1,"commentSize":2,"subComments":[{"id":4905686,"commentId":"4905686","gmtCreate":1624162250396,"gmtModify":1663229472040,"authorId":3576377533433583,"author":{"id":3576377533433583,"idStr":"3576377533433583","authorId":3576377533433583,"name":"llipinggg","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":164068713,"objectIdStr":"164068713","type":1,"supId":4905550,"supIdStr":"4905550","prevId":0,"prevIdStr":"0","content":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [开心] [微笑] [开心]","text":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [开心] [微笑] [开心]","html":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [开心] [微笑] [开心]"},{"id":4905722,"commentId":"4905722","gmtCreate":1624162321556,"gmtModify":1635307274031,"authorId":3571630433284403,"author":{"id":3571630433284403,"idStr":"3571630433284403","authorId":3571630433284403,"name":"cHao7","avatar":"https://static.tigerbbs.com/3800b5d66328f3184368a219227b02a3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3576377533433583,"repliedAuthor":{"id":3576377533433583,"idStr":"3576377533433583","authorId":3576377533433583,"name":"llipinggg","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":164068713,"objectIdStr":"164068713","type":1,"supId":4905550,"supIdStr":"4905550","prevId":4905686,"prevIdStr":"4905686","content":"whyyyyyyyy","text":"whyyyyyyyy","html":"whyyyyyyyy"}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":4905526,"commentId":"4905526","gmtCreate":1624161954190,"gmtModify":1663229474845,"authorId":3571630433284403,"author":{"id":3571630433284403,"idStr":"3571630433284403","authorId":3571630433284403,"name":"cHao7","avatar":"https://static.tigerbbs.com/3800b5d66328f3184368a219227b02a3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":164068713,"objectIdStr":"164068713","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"[难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过]","text":"[难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过]","html":"[难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过] [难过]","likeSize":1,"commentSize":3,"subComments":[{"id":4905539,"commentId":"4905539","gmtCreate":1624161984137,"gmtModify":1663229474941,"authorId":3574475026372561,"author":{"id":3574475026372561,"idStr":"3574475026372561","authorId":3574475026372561,"name":"B1B2","avatar":"https://static.tigerbbs.com/b4ccb7da6a3940242c0a0dc05f87652c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":164068713,"objectIdStr":"164068713","type":1,"supId":4905526,"supIdStr":"4905526","prevId":0,"prevIdStr":"0","content":"lol","text":"lol","html":"lol"},{"id":4905746,"commentId":"4905746","gmtCreate":1624162353761,"gmtModify":1663229472134,"authorId":3571630433284403,"author":{"id":3571630433284403,"idStr":"3571630433284403","authorId":3571630433284403,"name":"cHao7","avatar":"https://static.tigerbbs.com/3800b5d66328f3184368a219227b02a3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3574475026372561,"repliedAuthor":{"id":3574475026372561,"idStr":"3574475026372561","authorId":3574475026372561,"name":"B1B2","avatar":"https://static.tigerbbs.com/b4ccb7da6a3940242c0a0dc05f87652c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":164068713,"objectIdStr":"164068713","type":1,"supId":4905526,"supIdStr":"4905526","prevId":4905539,"prevIdStr":"4905539","content":"[贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑]","text":"[贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑]","html":"[贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑] [贱笑]"},{"id":4905732,"commentId":"4905732","gmtCreate":1624162339207,"gmtModify":1663229470646,"authorId":3571630433284403,"author":{"id":3571630433284403,"idStr":"3571630433284403","authorId":3571630433284403,"name":"cHao7","avatar":"https://static.tigerbbs.com/3800b5d66328f3184368a219227b02a3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3574475026372561,"repliedAuthor":{"id":3574475026372561,"idStr":"3574475026372561","authorId":3574475026372561,"name":"B1B2","avatar":"https://static.tigerbbs.com/b4ccb7da6a3940242c0a0dc05f87652c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":164068713,"objectIdStr":"164068713","type":1,"supId":4905526,"supIdStr":"4905526","prevId":4905539,"prevIdStr":"4905539","content":"to the moon b1b2 [冷漠] [冷漠] [冷漠]","text":"to the moon b1b2 [冷漠] [冷漠] [冷漠]","html":"to the moon b1b2 [冷漠] [冷漠] [冷漠]"}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":4905536,"commentId":"4905536","gmtCreate":1624161977895,"gmtModify":1635307295263,"authorId":3571630433284403,"author":{"id":3571630433284403,"idStr":"3571630433284403","authorId":3571630433284403,"name":"cHao7","avatar":"https://static.tigerbbs.com/3800b5d66328f3184368a219227b02a3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":164068713,"objectIdStr":"164068713","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"[害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞]","text":"[害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞]","html":"[害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞] [害羞]","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":4905541,"commentId":"4905541","gmtCreate":1624161991081,"gmtModify":1663229474333,"authorId":3576377533433583,"author":{"id":3576377533433583,"idStr":"3576377533433583","authorId":3576377533433583,"name":"llipinggg","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":164068713,"objectIdStr":"164068713","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"?","text":"?","html":"?","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":4905538,"commentId":"4905538","gmtCreate":1624161982117,"gmtModify":1663229473541,"authorId":3576377533433583,"author":{"id":3576377533433583,"idStr":"3576377533433583","authorId":3576377533433583,"name":"llipinggg","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":164068713,"objectIdStr":"164068713","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"?","text":"?","html":"?","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":4905459,"commentId":"4905459","gmtCreate":1624161857489,"gmtModify":1663229471941,"authorId":3579600897400043,"author":{"id":3579600897400043,"idStr":"3579600897400043","authorId":3579600897400043,"name":"Cyn198","avatar":"https://static.itradeup.com/news/93ec67f02db03a8c45239fa911c3cf4e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":164068713,"objectIdStr":"164068713","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Done. ","text":"Done. ","html":"Done. ","likeSize":1,"commentSize":1,"subComments":[{"id":4905862,"commentId":"4905862","gmtCreate":1624162623265,"gmtModify":1663229473938,"authorId":3571630433284403,"author":{"id":3571630433284403,"idStr":"3571630433284403","authorId":3571630433284403,"name":"cHao7","avatar":"https://static.tigerbbs.com/3800b5d66328f3184368a219227b02a3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":164068713,"objectIdStr":"164068713","type":1,"supId":4905459,"supIdStr":"4905459","prevId":0,"prevIdStr":"0","content":"trend","text":"trend","html":"trend"}],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/164068713"}